Geode Capital Management
SQZ

Geode Capital Management’s SQZ Biotechnologies Company SQZ Stock Holding History

Geode Capital Management’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-135,360
Closed -$36.5K – 4888
2023
Q2 		$36.5K Hold
135,360
– – ﹤0.01% 4571
2023
Q1 		$75.8K Hold
135,360
– – ﹤0.01% 4425
2022
Q4 		$100K Sell
135,360
-348
-0.3% -$760 ﹤0.01% 4403
2022
Q3 		$309K Buy
135,708
+14,108
+12% +$42.3K ﹤0.01% 3968
2022
Q2 		$386K Sell
121,600
-190,629
-61% -$686K ﹤0.01% 3902
2022
Q1 		$1.5M Buy
312,229
+8,729
+3% +$55.4K ﹤0.01% 3408
2021
Q4 		$2.71M Buy
303,500
+44,451
+17% +$545K ﹤0.01% 3221
2021
Q3 		$3.73M Buy
259,049
+13,941
+6% +$189K ﹤0.01% 3080
2021
Q2 		$3.54M Buy
245,108
+155,902
+175% +$2.04M ﹤0.01% 3099
2021
Q1 		$1.22M Buy
89,206
+14,522
+19% +$295K ﹤0.01% 3472
2020
Q4 		$2.16M Buy
+74,684
New +$1.91M ﹤0.01% 3042

Other funds holding SQZ

AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Geode Capital Management's SQZ Position: Q3 2023 in Review

Geode Capital Management sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 135,360 shares — an estimated $36.5K sold.

Geode Capital Management first reported a position in SQZ in Q4 2020 and held it in 11 quarters. The position peaked at $3.73M in Q3 2021. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

  • Geode Capital Management reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
  • Geode Capital Management sold 135,360 SQZ Biotechnologies Company shares in Q3 2023, an estimated $36.5K.
  • Geode Capital Management first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 11 quarters.
  • Geode Capital Management's SQZ Biotechnologies Company position peaked at $3.73M in Q3 2021.
  • 5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.